fanta.bio Sample: CNhs11973
19124 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1268 / 16329 (7.8%) | 372 / 163290 (0.2%) | −324.0 | −324.0 | 34.09 |
| HIF1A SRX11007095 | HK-2 Kidney | 2481 / 16329 (15.2%) | 827 / 163290 (0.5%) | −324.0 | −324.0 | 30.00 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1862 / 16329 (11.4%) | 692 / 163290 (0.4%) | −324.0 | −324.0 | 26.91 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1839 / 16329 (11.3%) | 718 / 163290 (0.4%) | −324.0 | −324.0 | 25.61 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2596 / 16329 (15.9%) | 1097 / 163290 (0.7%) | −324.0 | −324.0 | 23.66 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2506 / 16329 (15.3%) | 1061 / 163290 (0.6%) | −324.0 | −324.0 | 23.62 |
| HIF1A SRX20663235 | HK-2 Kidney | 557 / 16329 (3.4%) | 241 / 163290 (0.1%) | −324.0 | −324.0 | 23.11 |
| FOXP1 SRX736067 | LNCAP Prostate | 2169 / 16329 (13.3%) | 975 / 163290 (0.6%) | −324.0 | −324.0 | 22.25 |
| SCML2 SRX644728 | 293 Kidney | 1528 / 16329 (9.4%) | 710 / 163290 (0.4%) | −324.0 | −324.0 | 21.52 |
| TP53 SRX19538279 | Osteoblasts Bone | 551 / 16329 (3.4%) | 277 / 163290 (0.2%) | −324.0 | −324.0 | 19.89 |
| MYH11 SRX265221 | ME-1 Blood | 948 / 16329 (5.8%) | 564 / 163290 (0.3%) | −324.0 | −324.0 | 16.81 |
| MED1 SRX9419944 | BT-474 Breast | 3875 / 16329 (23.7%) | 2540 / 163290 (1.6%) | −324.0 | −324.0 | 15.26 |
| BRD4 SRX9419935 | BT-474 Breast | 3926 / 16329 (24.0%) | 2601 / 163290 (1.6%) | −324.0 | −324.0 | 15.09 |
| MED1 SRX9419945 | BT-474 Breast | 3943 / 16329 (24.1%) | 2618 / 163290 (1.6%) | −324.0 | −324.0 | 15.06 |
| BRD4 SRX9419937 | BT-474 Breast | 3909 / 16329 (23.9%) | 2607 / 163290 (1.6%) | −324.0 | −324.0 | 14.99 |
| BRD4 SRX9419938 | BT-474 Breast | 3968 / 16329 (24.3%) | 2695 / 163290 (1.7%) | −324.0 | −324.0 | 14.72 |
| MED1 SRX9419946 | BT-474 Breast | 4010 / 16329 (24.6%) | 2738 / 163290 (1.7%) | −324.0 | −324.0 | 14.65 |
| BRD4 SRX9419936 | BT-474 Breast | 4019 / 16329 (24.6%) | 2749 / 163290 (1.7%) | −324.0 | −324.0 | 14.62 |
| MED1 SRX9419947 | BT-474 Breast | 3883 / 16329 (23.8%) | 2703 / 163290 (1.7%) | −324.0 | −324.0 | 14.37 |
| EZH2 SRX2146136 | LNCAP Prostate | 8673 / 16329 (53.1%) | 7668 / 163290 (4.7%) | −324.0 | −324.0 | 11.31 |
| BRD4 SRX736201 | 90-8TL Neural | 6421 / 16329 (39.3%) | 6316 / 163290 (3.9%) | −324.0 | −324.0 | 10.17 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 790 / 16329 (4.8%) | 907 / 163290 (0.6%) | −324.0 | −324.0 | 8.71 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1893 / 16329 (11.6%) | 2547 / 163290 (1.6%) | −324.0 | −324.0 | 7.43 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1386 / 16329 (8.5%) | 3519 / 163290 (2.2%) | −324.0 | −324.0 | 3.94 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1667 / 16329 (10.2%) | 4886 / 163290 (3.0%) | −324.0 | −324.0 | 3.41 |
| PBX4 SRX2731658 | PC-3 Prostate | 703 / 16329 (4.3%) | 25742 / 163290 (15.8%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757325 | H2052 Lung | 495 / 16329 (3.0%) | 19837 / 163290 (12.1%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150478 | MCF 10A Breast | 483 / 16329 (3.0%) | 19649 / 163290 (12.0%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757326 | H2052 Lung | 419 / 16329 (2.6%) | 17776 / 163290 (10.9%) | −324.0 | −324.0 | 0.24 |
| FOS SRX150477 | MCF 10A Breast | 453 / 16329 (2.8%) | 19246 / 163290 (11.8%) | −324.0 | −324.0 | 0.24 |
| TP53 SRX19538274 | U2OS Bone | 446 / 16329 (2.7%) | 163 / 163290 (0.1%) | −321.2 | −318.2 | 27.36 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 722 / 16329 (4.4%) | 872 / 163290 (0.5%) | −317.8 | −314.8 | 8.28 |
| TP53 SRX19538268 | U2OS Bone | 444 / 16329 (2.7%) | 169 / 163290 (0.1%) | −316.3 | −313.3 | 26.27 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 468 / 16329 (2.9%) | 18184 / 163290 (11.1%) | −315.6 | −312.6 | 0.26 |
| TP53 SRX19538276 | U2OS Bone | 445 / 16329 (2.7%) | 175 / 163290 (0.1%) | −314.1 | −311.1 | 25.43 |
| AGO2 SRX4708039 | Hep G2 Liver | 1991 / 16329 (12.2%) | 7224 / 163290 (4.4%) | −306.5 | −303.6 | 2.76 |
| FOS SRX4192880 | MCF 10A Breast | 346 / 16329 (2.1%) | 15632 / 163290 (9.6%) | −303.3 | −300.4 | 0.22 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 440 / 16329 (2.7%) | 204 / 163290 (0.1%) | −295.6 | −292.7 | 21.57 |
| FOXA1 SRX4815198 | MCF-7 Breast | 844 / 16329 (5.2%) | 23529 / 163290 (14.4%) | −292.3 | −289.4 | 0.36 |
| TP53 SRX19538267 | U2OS Bone | 404 / 16329 (2.5%) | 154 / 163290 (0.1%) | −287.6 | −284.7 | 26.23 |
| TP53 SRX19538280 | Osteoblasts Bone | 431 / 16329 (2.6%) | 206 / 163290 (0.1%) | −286.8 | −283.8 | 20.92 |
| FOXA1 SRX4815197 | MCF-7 Breast | 593 / 16329 (3.6%) | 19300 / 163290 (11.8%) | −283.1 | −280.2 | 0.31 |
| TP53 SRX19538273 | U2OS Bone | 395 / 16329 (2.4%) | 152 / 163290 (0.1%) | −280.4 | −277.5 | 25.99 |
| 5-mC SRX882970 | LNCAP Prostate | 3029 / 16329 (18.5%) | 14661 / 163290 (9.0%) | −279.4 | −276.5 | 2.07 |
| ESR1 SRX7624157 | MCF-7 Breast | 645 / 16329 (4.0%) | 19898 / 163290 (12.2%) | −275.6 | −272.8 | 0.32 |
| TP53 SRX19538275 | U2OS Bone | 399 / 16329 (2.4%) | 169 / 163290 (0.1%) | −275.5 | −272.7 | 23.61 |
| IRF3 SRX11453858 | Hep G2 Liver | 331 / 16329 (2.0%) | 63 / 163290 (0.0%) | −274.6 | −271.8 | 52.54 |
| TP53 SRX19538281 | Osteoblasts Bone | 459 / 16329 (2.8%) | 296 / 163290 (0.2%) | −274.4 | −271.6 | 15.51 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 886 / 16329 (5.4%) | 23535 / 163290 (14.4%) | −273.7 | −270.9 | 0.38 |
| 5-mC SRX882968 | LNCAP Prostate | 2985 / 16329 (18.3%) | 14485 / 163290 (8.9%) | −273.0 | −270.2 | 2.06 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 576 / 16329 (3.5%) | 628 / 163290 (0.4%) | −268.7 | −265.9 | 9.17 |
| FOXA1 SRX3931044 | MCF-7 Breast | 531 / 16329 (3.3%) | 17820 / 163290 (10.9%) | −268.3 | −265.5 | 0.30 |
| FOS SRX150517 | MCF 10A Breast | 398 / 16329 (2.4%) | 15515 / 163290 (9.5%) | −267.1 | −264.3 | 0.26 |
| JUNB SRX8488088 | SUM 229PE Breast | 462 / 16329 (2.8%) | 16595 / 163290 (10.2%) | −266.2 | −263.4 | 0.28 |
| FOXA1 SRX176862 | MCF-7 Breast | 294 / 16329 (1.8%) | 13515 / 163290 (8.3%) | −263.3 | −260.6 | 0.22 |
| GATA3 SRX190239 | MCF-7 Breast | 336 / 16329 (2.1%) | 14204 / 163290 (8.7%) | −260.2 | −257.4 | 0.24 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 906 / 16329 (5.5%) | 23334 / 163290 (14.3%) | −259.2 | −256.4 | 0.39 |
| RELA SRX2207673 | HUVEC Cardiovascular | 995 / 16329 (6.1%) | 24493 / 163290 (15.0%) | −255.4 | −252.7 | 0.41 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 639 / 16329 (3.9%) | 900 / 163290 (0.6%) | −254.4 | −251.7 | 7.10 |
| TP53 SRX19538269 | U2OS Bone | 487 / 16329 (3.0%) | 431 / 163290 (0.3%) | −253.3 | −250.6 | 11.30 |
| FOS SRX150476 | MCF 10A Breast | 424 / 16329 (2.6%) | 15547 / 163290 (9.5%) | −253.2 | −250.4 | 0.27 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 616 / 16329 (3.8%) | 18699 / 163290 (11.5%) | −252.7 | −250.0 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 388 / 16329 (2.4%) | 14898 / 163290 (9.1%) | −252.3 | −249.6 | 0.26 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 626 / 16329 (3.8%) | 18844 / 163290 (11.5%) | −252.3 | −249.6 | 0.33 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 255 / 16329 (1.6%) | 12442 / 163290 (7.6%) | −251.9 | −249.2 | 0.20 |
| Epitope tags SRX10549776 | K-562 Blood | 1480 / 16329 (9.1%) | 4983 / 163290 (3.1%) | −251.3 | −248.6 | 2.97 |
| GATA3 SRX190194 | SK-N-SH Neural | 626 / 16329 (3.8%) | 18797 / 163290 (11.5%) | −250.8 | −248.1 | 0.33 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 552 / 16329 (3.4%) | 17589 / 163290 (10.8%) | −250.0 | −247.4 | 0.31 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 262 / 16329 (1.6%) | 12519 / 163290 (7.7%) | −249.8 | −247.1 | 0.21 |
| FOXA1 SRX176863 | MCF-7 Breast | 278 / 16329 (1.7%) | 12817 / 163290 (7.8%) | −249.7 | −247.0 | 0.22 |
| ESR1 SRX371478 | MCF-7 Breast | 302 / 16329 (1.8%) | 13196 / 163290 (8.1%) | −247.3 | −244.6 | 0.23 |
| AR SRX1067071 | LHSAR Prostate | 504 / 16329 (3.1%) | 16707 / 163290 (10.2%) | −247.1 | −244.5 | 0.30 |
| YAP1 SRX5718140 | 293 Kidney | 423 / 16329 (2.6%) | 15285 / 163290 (9.4%) | −245.1 | −242.5 | 0.28 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 653 / 16329 (4.0%) | 18988 / 163290 (11.6%) | −243.8 | −241.2 | 0.34 |
| FOXA1 SRX1161177 | MCF-7 Breast | 229 / 16329 (1.4%) | 11688 / 163290 (7.2%) | −243.2 | −240.5 | 0.20 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 436 / 16329 (2.7%) | 15418 / 163290 (9.4%) | −242.3 | −239.6 | 0.28 |
| TCF12 SRX190356 | SK-N-SH Neural | 755 / 16329 (4.6%) | 20482 / 163290 (12.5%) | −241.7 | −239.1 | 0.37 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 300 / 16329 (1.8%) | 12977 / 163290 (7.9%) | −240.9 | −238.3 | 0.23 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 356 / 16329 (2.2%) | 13987 / 163290 (8.6%) | −240.9 | −238.3 | 0.25 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1115 / 16329 (6.8%) | 25666 / 163290 (15.7%) | −240.8 | −238.2 | 0.43 |
| ESR1 SRX371469 | MCF-7 Breast | 236 / 16329 (1.4%) | 11742 / 163290 (7.2%) | −240.3 | −237.7 | 0.20 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 552 / 16329 (3.4%) | 678 / 163290 (0.4%) | −239.9 | −237.3 | 8.14 |
| JUNB SRX8488073 | SUM 229PE Breast | 492 / 16329 (3.0%) | 16268 / 163290 (10.0%) | −239.4 | −236.8 | 0.30 |
| ESR1 SRX4367193 | MCF-7 Breast | 918 / 16329 (5.6%) | 22813 / 163290 (14.0%) | −239.3 | −236.7 | 0.40 |
| SS18 SRX3468047 | Fibroblasts Others | 695 / 16329 (4.3%) | 19469 / 163290 (11.9%) | −238.8 | −236.2 | 0.36 |
| 5-mC SRX882965 | LNCAP Prostate | 2432 / 16329 (14.9%) | 11337 / 163290 (6.9%) | −238.2 | −235.6 | 2.15 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 445 / 16329 (2.7%) | 15436 / 163290 (9.5%) | −237.9 | −235.4 | 0.29 |
| ESR1 SRX20282961 | MCF-7 Breast | 308 / 16329 (1.9%) | 13033 / 163290 (8.0%) | −237.9 | −235.3 | 0.24 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 356 / 16329 (2.2%) | 13892 / 163290 (8.5%) | −237.7 | −235.1 | 0.26 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 517 / 16329 (3.2%) | 16587 / 163290 (10.2%) | −236.5 | −234.0 | 0.31 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 597 / 16329 (3.7%) | 17853 / 163290 (10.9%) | −236.1 | −233.6 | 0.33 |
| TLE3 SRX4815191 | MCF-7 Breast | 217 / 16329 (1.3%) | 11247 / 163290 (6.9%) | −235.9 | −233.4 | 0.19 |
| AR SRX1067070 | LHSAR Prostate | 674 / 16329 (4.1%) | 19043 / 163290 (11.7%) | −235.7 | −233.1 | 0.35 |
| RUNX1 SRX2513054 | 293 Kidney | 3215 / 16329 (19.7%) | 17166 / 163290 (10.5%) | −233.4 | −230.8 | 1.87 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 922 / 16329 (5.6%) | 22650 / 163290 (13.9%) | −233.2 | −230.6 | 0.41 |
| SMARCA2 SRX8119677 | MeT-5A Others | 423 / 16329 (2.6%) | 14897 / 163290 (9.1%) | −232.6 | −230.0 | 0.28 |
| JUN SRX17561461 | LPS141 Adipocyte | 367 / 16329 (2.2%) | 13918 / 163290 (8.5%) | −232.2 | −229.7 | 0.26 |
| FOXA1 SRX371483 | MCF-7 Breast | 281 / 16329 (1.7%) | 12332 / 163290 (7.6%) | −231.1 | −228.5 | 0.23 |
| TP53 SRX19538270 | U2OS Bone | 460 / 16329 (2.8%) | 438 / 163290 (0.3%) | −230.6 | −228.1 | 10.50 |
| IRF3 SRX11453861 | Hep G2 Liver | 286 / 16329 (1.8%) | 65 / 163290 (0.0%) | −229.7 | −227.2 | 44.00 |
| KAT6A SRX20971022 | Fibroblasts Others | 286 / 16329 (1.8%) | 65 / 163290 (0.0%) | −229.7 | −227.2 | 44.00 |
| FOXA1 SRX1161176 | MCF-7 Breast | 226 / 16329 (1.4%) | 11230 / 163290 (6.9%) | −229.2 | −226.7 | 0.20 |
| ESR1 SRX371479 | MCF-7 Breast | 212 / 16329 (1.3%) | 10945 / 163290 (6.7%) | −228.8 | −226.3 | 0.19 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 166 / 16329 (1.0%) | 9992 / 163290 (6.1%) | −228.2 | −225.7 | 0.17 |
| FOXA1 SRX371482 | MCF-7 Breast | 389 / 16329 (2.4%) | 14099 / 163290 (8.6%) | −225.6 | −223.1 | 0.28 |
| FOXA1 SRX371481 | MCF-7 Breast | 266 / 16329 (1.6%) | 11852 / 163290 (7.3%) | −224.2 | −221.7 | 0.22 |
| VGLL1 SRX24602130 | BT-20 Breast | 253 / 16329 (1.5%) | 11602 / 163290 (7.1%) | −224.1 | −221.6 | 0.22 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 339 / 16329 (2.1%) | 13166 / 163290 (8.1%) | −223.7 | −221.2 | 0.26 |
| ESR1 SRX20282960 | MCF-7 Breast | 290 / 16329 (1.8%) | 12265 / 163290 (7.5%) | −223.0 | −220.6 | 0.24 |
| SMARCA4 SRX5212366 | Mel270 Others | 350 / 16329 (2.1%) | 13327 / 163290 (8.2%) | −222.7 | −220.2 | 0.26 |
| ESR1 SRX371471 | ZR-75-1 Breast | 272 / 16329 (1.7%) | 11916 / 163290 (7.3%) | −222.5 | −220.0 | 0.23 |
| FOXA1 SRX1161173 | MCF-7 Breast | 183 / 16329 (1.1%) | 10175 / 163290 (6.2%) | −222.1 | −219.6 | 0.18 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2092 / 16329 (12.8%) | 9334 / 163290 (5.7%) | −222.0 | −219.6 | 2.24 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 234 / 16329 (1.4%) | 11168 / 163290 (6.8%) | −221.5 | −219.0 | 0.21 |
| BRD1 SRX286203 | RKO Digestive tract | 1227 / 16329 (7.5%) | 3940 / 163290 (2.4%) | −221.3 | −218.9 | 3.11 |
| KAT7 SRX101303 | RKO Digestive tract | 1395 / 16329 (8.5%) | 4932 / 163290 (3.0%) | −219.4 | −216.9 | 2.83 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 854 / 16329 (5.2%) | 21137 / 163290 (12.9%) | −218.6 | −216.2 | 0.40 |
| SMARCA4 SRX5212357 | Mel270 Others | 389 / 16329 (2.4%) | 13852 / 163290 (8.5%) | −217.8 | −215.3 | 0.28 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 343 / 16329 (2.1%) | 13045 / 163290 (8.0%) | −217.4 | −214.9 | 0.26 |
| ESR1 SRX176860 | MCF-7 Breast | 459 / 16329 (2.8%) | 15017 / 163290 (9.2%) | −217.3 | −214.8 | 0.31 |
| FOS SRX4192879 | MCF 10A Breast | 296 / 16329 (1.8%) | 12202 / 163290 (7.5%) | −217.2 | −214.8 | 0.24 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 457 / 16329 (2.8%) | 14977 / 163290 (9.2%) | −217.2 | −214.8 | 0.31 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 223 / 16329 (1.4%) | 10806 / 163290 (6.6%) | −216.4 | −214.0 | 0.21 |
| FOXA1 SRX1161175 | MCF-7 Breast | 173 / 16329 (1.1%) | 9800 / 163290 (6.0%) | −216.2 | −213.7 | 0.18 |
| JUN SRX4192884 | MCF 10A Breast | 194 / 16329 (1.2%) | 10218 / 163290 (6.3%) | −215.7 | −213.3 | 0.19 |
| SMARCA4 SRX5212362 | Mel270 Others | 489 / 16329 (3.0%) | 15433 / 163290 (9.5%) | −215.1 | −212.7 | 0.32 |
| FOXA1 SRX100454 | T-47D Breast | 347 / 16329 (2.1%) | 13046 / 163290 (8.0%) | −215.1 | −212.6 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 170 / 16329 (1.0%) | 9704 / 163290 (5.9%) | −214.9 | −212.5 | 0.18 |
| CEBPB SRX150632 | HeLa Uterus | 663 / 16329 (4.1%) | 18157 / 163290 (11.1%) | −214.8 | −212.4 | 0.37 |
| ESR1 SRX20282939 | MCF-7 Breast | 301 / 16329 (1.8%) | 12207 / 163290 (7.5%) | −214.5 | −212.1 | 0.25 |
| ESR1 SRX371470 | ZR-75-1 Breast | 228 / 16329 (1.4%) | 10835 / 163290 (6.6%) | −214.0 | −211.6 | 0.21 |
| AGO2 SRX6783957 | Hep G2 Liver | 1278 / 16329 (7.8%) | 4331 / 163290 (2.7%) | −213.6 | −211.2 | 2.95 |
| ESR1 SRX176861 | MCF-7 Breast | 469 / 16329 (2.9%) | 14976 / 163290 (9.2%) | −211.0 | −208.6 | 0.31 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 879 / 16329 (5.4%) | 21224 / 163290 (13.0%) | −211.0 | −208.6 | 0.41 |
| AGO2 SRX6783958 | Hep G2 Liver | 1247 / 16329 (7.6%) | 4197 / 163290 (2.6%) | −210.4 | −208.0 | 2.97 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 230 / 16329 (1.4%) | 10765 / 163290 (6.6%) | −210.4 | −208.0 | 0.21 |
| ESR1 SRX1531791 | MCF-7 Breast | 249 / 16329 (1.5%) | 11114 / 163290 (6.8%) | −210.0 | −207.6 | 0.22 |
| TP53 SRX19538282 | Osteoblasts Bone | 385 / 16329 (2.4%) | 309 / 163290 (0.2%) | −209.6 | −207.3 | 12.46 |
| JUNB SRX8488074 | SUM 229PE Breast | 367 / 16329 (2.2%) | 13215 / 163290 (8.1%) | −209.4 | −207.1 | 0.28 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 807 / 16329 (4.9%) | 20106 / 163290 (12.3%) | −209.1 | −206.7 | 0.40 |
| NR2F2 SRX190293 | MCF-7 Breast | 268 / 16329 (1.6%) | 11437 / 163290 (7.0%) | −208.8 | −206.4 | 0.23 |
| ARID1A SRX5089376 | MCF-7 Breast | 211 / 16329 (1.3%) | 10349 / 163290 (6.3%) | −208.6 | −206.2 | 0.20 |
| ESR1 SRX371468 | MCF-7 Breast | 143 / 16329 (0.9%) | 8957 / 163290 (5.5%) | −208.3 | −206.0 | 0.16 |
| FOXA1 SRX1161174 | MCF-7 Breast | 269 / 16329 (1.6%) | 11438 / 163290 (7.0%) | −208.3 | −205.9 | 0.24 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 925 / 16329 (5.7%) | 21720 / 163290 (13.3%) | −206.7 | −204.3 | 0.43 |
| JUNB SRX8488089 | SUM 229PE Breast | 256 / 16329 (1.6%) | 11145 / 163290 (6.8%) | −206.4 | −204.1 | 0.23 |
| EP300 SRX2194266 | SUM 159PT Breast | 496 / 16329 (3.0%) | 15260 / 163290 (9.3%) | −206.3 | −203.9 | 0.33 |
| ESR1 SRX194572 | MCF-7 Breast | 143 / 16329 (0.9%) | 8898 / 163290 (5.4%) | −206.2 | −203.9 | 0.16 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 231 / 16329 (1.4%) | 10660 / 163290 (6.5%) | −206.0 | −203.7 | 0.22 |
| AR SRX10820653 | LNCAP Prostate | 333 / 16329 (2.0%) | 197 / 163290 (0.1%) | −205.7 | −203.3 | 16.90 |
| GATA3 SRX176864 | MCF-7 Breast | 182 / 16329 (1.1%) | 9668 / 163290 (5.9%) | −204.8 | −202.5 | 0.19 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 759 / 16329 (4.6%) | 19227 / 163290 (11.8%) | −204.2 | −201.9 | 0.39 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 262 / 16329 (1.6%) | 11174 / 163290 (6.8%) | −203.7 | −201.3 | 0.23 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 580 / 16329 (3.6%) | 16481 / 163290 (10.1%) | −203.1 | −200.8 | 0.35 |
| SMARCA4 SRX5212371 | Mel270 Others | 405 / 16329 (2.5%) | 13654 / 163290 (8.4%) | −202.9 | −200.6 | 0.30 |
| WWTR1 SRX10119367 | MCF 10A Breast | 315 / 16329 (1.9%) | 12101 / 163290 (7.4%) | −202.7 | −200.4 | 0.26 |
| GATA3 SRX5057632 | MCF-7 Breast | 154 / 16329 (0.9%) | 9024 / 163290 (5.5%) | −202.4 | −200.1 | 0.17 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 581 / 16329 (3.6%) | 16464 / 163290 (10.1%) | −202.1 | −199.8 | 0.35 |
| JUN SRX6582171 | GM07492 Others | 586 / 16329 (3.6%) | 16529 / 163290 (10.1%) | −201.7 | −199.4 | 0.35 |
| ESR1 SRX371467 | MCF-7 Breast | 291 / 16329 (1.8%) | 11627 / 163290 (7.1%) | −201.3 | −199.0 | 0.25 |
| FOXA1 SRX11222441 | MCF-7 Breast | 193 / 16329 (1.2%) | 9773 / 163290 (6.0%) | −200.8 | −198.5 | 0.20 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 523 / 16329 (3.2%) | 15507 / 163290 (9.5%) | −200.7 | −198.4 | 0.34 |
| FOXA1 SRX1787653 | MCF-7 Breast | 207 / 16329 (1.3%) | 10043 / 163290 (6.2%) | −200.6 | −198.3 | 0.21 |
| ESR1 SRX194569 | MCF-7 Breast | 290 / 16329 (1.8%) | 11584 / 163290 (7.1%) | −200.5 | −198.1 | 0.25 |
| STAT3 SRX2020842 | HCC70 Breast | 526 / 16329 (3.2%) | 15544 / 163290 (9.5%) | −200.4 | −198.1 | 0.34 |
| BRPF3 SRX796085 | RKO Digestive tract | 1089 / 16329 (6.7%) | 3441 / 163290 (2.1%) | −200.1 | −197.8 | 3.16 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 279 / 16329 (1.7%) | 11376 / 163290 (7.0%) | −200.1 | −197.8 | 0.25 |
| ESR1 SRX20282972 | MCF-7 Breast | 311 / 16329 (1.9%) | 11936 / 163290 (7.3%) | −199.6 | −197.3 | 0.26 |
| BRD4 SRX736204 | 90-8TL Neural | 955 / 16329 (5.8%) | 2728 / 163290 (1.7%) | −199.5 | −197.2 | 3.50 |
| RAC1 SRX10365541 | MCF-7 Breast | 114 / 16329 (0.7%) | 8080 / 163290 (4.9%) | −199.4 | −197.1 | 0.14 |
| ESR1 SRX2943591 | MCF-7 Breast | 167 / 16329 (1.0%) | 9196 / 163290 (5.6%) | −198.9 | −196.6 | 0.18 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 242 / 16329 (1.5%) | 10654 / 163290 (6.5%) | −198.7 | −196.4 | 0.23 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 201 / 16329 (1.2%) | 9857 / 163290 (6.0%) | −198.2 | −195.9 | 0.20 |
| ESR1 SRX20282954 | MCF-7 Breast | 306 / 16329 (1.9%) | 11799 / 163290 (7.2%) | −198.0 | −195.8 | 0.26 |
| ARID1A SRX5089379 | MCF-7 Breast | 263 / 16329 (1.6%) | 11018 / 163290 (6.7%) | −197.9 | −195.6 | 0.24 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 408 / 16329 (2.5%) | 13543 / 163290 (8.3%) | −197.9 | −195.6 | 0.30 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 297 / 16329 (1.8%) | 11613 / 163290 (7.1%) | −197.2 | −194.9 | 0.26 |
| ESR1 SRX10365536 | MCF-7 Breast | 118 / 16329 (0.7%) | 8086 / 163290 (5.0%) | −196.4 | −194.1 | 0.15 |
| TEAD1 SRX3401272 | MCF-7 Breast | 190 / 16329 (1.2%) | 9584 / 163290 (5.9%) | −196.2 | −194.0 | 0.20 |
| TP53 SRX396254 | Fibroblasts Others | 922 / 16329 (5.6%) | 2596 / 163290 (1.6%) | −195.9 | −193.6 | 3.55 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 257 / 16329 (1.6%) | 10845 / 163290 (6.6%) | −195.9 | −193.6 | 0.24 |
| PRRX1 SRX15235713 | Hs 578T Breast | 344 / 16329 (2.1%) | 12393 / 163290 (7.6%) | −195.7 | −193.5 | 0.28 |
| JUNB SRX10119386 | MCF 10A Breast | 245 / 16329 (1.5%) | 10618 / 163290 (6.5%) | −195.7 | −193.4 | 0.23 |
| JUN SRX883584 | MDA-MB-231 Breast | 467 / 16329 (2.9%) | 14440 / 163290 (8.8%) | −195.7 | −193.4 | 0.32 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 176 / 16329 (1.1%) | 9286 / 163290 (5.7%) | −195.7 | −193.4 | 0.19 |
| PBX3 SRX190343 | SK-N-SH Neural | 648 / 16329 (4.0%) | 17261 / 163290 (10.6%) | −195.6 | −193.3 | 0.38 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 254 / 16329 (1.6%) | 10780 / 163290 (6.6%) | −195.5 | −193.2 | 0.24 |
| EP300 SRX2194265 | SUM 159PT Breast | 471 / 16329 (2.9%) | 14476 / 163290 (8.9%) | −194.8 | −192.5 | 0.33 |
| FOXA1 SRX371480 | MCF-7 Breast | 172 / 16329 (1.1%) | 9179 / 163290 (5.6%) | −194.7 | −192.5 | 0.19 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 520 / 16329 (3.2%) | 15256 / 163290 (9.3%) | −194.7 | −192.4 | 0.34 |
| FOXA2 SRX3230382 | Hep G2 Liver | 398 / 16329 (2.4%) | 13274 / 163290 (8.1%) | −194.6 | −192.4 | 0.30 |
| BRPF3 SRX796084 | RKO Digestive tract | 1489 / 16329 (9.1%) | 5906 / 163290 (3.6%) | −194.0 | −191.8 | 2.52 |
| RAC1 SRX10365543 | MCF-7 Breast | 121 / 16329 (0.7%) | 8079 / 163290 (4.9%) | −193.7 | −191.5 | 0.15 |
| BRPF3 SRX796086 | RKO Digestive tract | 1436 / 16329 (8.8%) | 5578 / 163290 (3.4%) | −193.6 | −191.4 | 2.57 |
| ARID5B SRX3230377 | Hep G2 Liver | 784 / 16329 (4.8%) | 19205 / 163290 (11.8%) | −193.6 | −191.3 | 0.41 |
| FOXA1 SRX3931043 | MCF-7 Breast | 287 / 16329 (1.8%) | 11322 / 163290 (6.9%) | −193.5 | −191.3 | 0.25 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 706 / 16329 (4.3%) | 18050 / 163290 (11.1%) | −193.3 | −191.1 | 0.39 |
| TP53 SRX19538271 | U2OS Bone | 624 / 16329 (3.8%) | 1216 / 163290 (0.7%) | −193.1 | −190.9 | 5.13 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 240 / 16329 (1.5%) | 10434 / 163290 (6.4%) | −192.5 | −190.3 | 0.23 |
| FOXA1 SRX3923514 | MCF-7 Breast | 290 / 16329 (1.8%) | 11337 / 163290 (6.9%) | −192.3 | −190.0 | 0.26 |
| JUNB SRX4192882 | MCF 10A Breast | 210 / 16329 (1.3%) | 9852 / 163290 (6.0%) | −192.2 | −190.0 | 0.21 |
| ESR1 SRX371477 | MCF-7 Breast | 110 / 16329 (0.7%) | 7779 / 163290 (4.8%) | −191.6 | −189.4 | 0.14 |
| ESR1 SRX10365535 | MCF-7 Breast | 215 / 16329 (1.3%) | 9921 / 163290 (6.1%) | −191.2 | −189.0 | 0.22 |
| ESR1 SRX2881000 | MCF-7 Breast | 239 / 16329 (1.5%) | 10341 / 163290 (6.3%) | −190.2 | −187.9 | 0.23 |
| NKX2-1 SRX2164786 | A549 Lung | 511 / 16329 (3.1%) | 14953 / 163290 (9.2%) | −190.1 | −187.9 | 0.34 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 217 / 16329 (1.3%) | 9922 / 163290 (6.1%) | −190.0 | −187.8 | 0.22 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 265 / 16329 (1.6%) | 10806 / 163290 (6.6%) | −189.7 | −187.5 | 0.25 |
| FOXL2 SRX6957431 | KGN Gonad | 727 / 16329 (4.5%) | 18227 / 163290 (11.2%) | −189.7 | −187.5 | 0.40 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 262 / 16329 (1.6%) | 10750 / 163290 (6.6%) | −189.6 | −187.4 | 0.24 |
| AR SRX9469988 | LAPC-4 Prostate | 400 / 16329 (2.4%) | 13138 / 163290 (8.0%) | −189.4 | −187.2 | 0.30 |
| WWTR1 SRX10119378 | MCF 10A Breast | 312 / 16329 (1.9%) | 11635 / 163290 (7.1%) | −189.4 | −187.2 | 0.27 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 451 / 16329 (2.8%) | 13970 / 163290 (8.6%) | −189.3 | −187.1 | 0.32 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 268 / 16329 (1.6%) | 10847 / 163290 (6.6%) | −189.2 | −187.0 | 0.25 |
| JUND SRX190357 | SK-N-SH Neural | 376 / 16329 (2.3%) | 12727 / 163290 (7.8%) | −189.1 | −186.9 | 0.30 |
| ESR1 SRX2881002 | MCF-7 Breast | 263 / 16329 (1.6%) | 10748 / 163290 (6.6%) | −188.9 | −186.7 | 0.24 |
| AR SRX1067066 | LHSAR Prostate | 667 / 16329 (4.1%) | 17295 / 163290 (10.6%) | −188.5 | −186.3 | 0.39 |
| STAT3 SRX150479 | MCF 10A Breast | 256 / 16329 (1.6%) | 10607 / 163290 (6.5%) | −188.4 | −186.3 | 0.24 |
| FOXA1 SRX11222442 | MCF-7 Breast | 175 / 16329 (1.1%) | 9052 / 163290 (5.5%) | −188.1 | −186.0 | 0.19 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 408 / 16329 (2.5%) | 13221 / 163290 (8.1%) | −187.9 | −185.7 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 536 / 16329 (3.3%) | 907 / 163290 (0.6%) | −186.3 | −184.1 | 5.91 |
| FOXA1 SRX3931054 | MCF-7 Breast | 270 / 16329 (1.7%) | 10787 / 163290 (6.6%) | −186.0 | −183.9 | 0.25 |
| EP300 SRX2671813 | Fibroblasts Others | 232 / 16329 (1.4%) | 10084 / 163290 (6.2%) | −185.9 | −183.8 | 0.23 |
| ESR1 SRX4367192 | MCF-7 Breast | 649 / 16329 (4.0%) | 16918 / 163290 (10.4%) | −185.5 | −183.3 | 0.38 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 319 / 16329 (2.0%) | 11637 / 163290 (7.1%) | −185.5 | −183.3 | 0.27 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 259 / 16329 (1.6%) | 10568 / 163290 (6.5%) | −185.4 | −183.2 | 0.25 |
| YAP1 SRX10119364 | MCF 10A Breast | 232 / 16329 (1.4%) | 10059 / 163290 (6.2%) | −185.0 | −182.8 | 0.23 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 267 / 16329 (1.6%) | 10703 / 163290 (6.6%) | −185.0 | −182.8 | 0.25 |
| ESR1 SRX371475 | BT-474 Breast | 119 / 16329 (0.7%) | 7795 / 163290 (4.8%) | −184.9 | −182.7 | 0.15 |
| FOXA1 SRX3931055 | MCF-7 Breast | 238 / 16329 (1.5%) | 10165 / 163290 (6.2%) | −184.9 | −182.7 | 0.23 |
| AR SRX1067067 | LHSAR Prostate | 535 / 16329 (3.3%) | 15129 / 163290 (9.3%) | −184.2 | −182.0 | 0.35 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 112 / 16329 (0.7%) | 7610 / 163290 (4.7%) | −183.8 | −181.7 | 0.15 |
| STAT3 SRX150630 | MCF 10A Breast | 261 / 16329 (1.6%) | 10551 / 163290 (6.5%) | −183.7 | −181.6 | 0.25 |
| AR SRX10820651 | LNCAP Prostate | 347 / 16329 (2.1%) | 296 / 163290 (0.2%) | −183.6 | −181.5 | 11.72 |
| FOXA1 SRX11222437 | MCF-7 Breast | 200 / 16329 (1.2%) | 9410 / 163290 (5.8%) | −183.6 | −181.5 | 0.21 |
| STAT3 SRX150536 | MCF 10A Breast | 328 / 16329 (2.0%) | 11725 / 163290 (7.2%) | −183.4 | −181.2 | 0.28 |
| ESR1 SRX20282946 | MCF-7 Breast | 154 / 16329 (0.9%) | 8488 / 163290 (5.2%) | −183.3 | −181.1 | 0.18 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 553 / 16329 (3.4%) | 15375 / 163290 (9.4%) | −183.2 | −181.0 | 0.36 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 263 / 16329 (1.6%) | 10570 / 163290 (6.5%) | −183.1 | −181.0 | 0.25 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 551 / 16329 (3.4%) | 15332 / 163290 (9.4%) | −182.9 | −180.8 | 0.36 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 814 / 16329 (5.0%) | 2184 / 163290 (1.3%) | −182.8 | −180.6 | 3.73 |
| FOSL2 SRX190296 | SK-N-SH Neural | 415 / 16329 (2.5%) | 13165 / 163290 (8.1%) | −182.6 | −180.5 | 0.32 |
| FOXA1 SRX100506 | Hep G2 Liver | 411 / 16329 (2.5%) | 13094 / 163290 (8.0%) | −182.6 | −180.4 | 0.31 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 397 / 16329 (2.4%) | 12852 / 163290 (7.9%) | −182.3 | −180.1 | 0.31 |
| NR3C1 SRX17639412 | A549 Lung | 330 / 16329 (2.0%) | 11707 / 163290 (7.2%) | −181.7 | −179.5 | 0.28 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 301 / 16329 (1.8%) | 11190 / 163290 (6.9%) | −181.2 | −179.1 | 0.27 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 397 / 16329 (2.4%) | 12811 / 163290 (7.8%) | −181.0 | −178.8 | 0.31 |
| TLE3 SRX4815192 | MCF-7 Breast | 265 / 16329 (1.6%) | 10539 / 163290 (6.5%) | −180.9 | −178.8 | 0.25 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 439 / 16329 (2.7%) | 13476 / 163290 (8.3%) | −180.4 | −178.2 | 0.33 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 494 / 16329 (3.0%) | 14345 / 163290 (8.8%) | −180.1 | −178.0 | 0.34 |
| ESR1 SRX20282973 | MCF-7 Breast | 367 / 16329 (2.2%) | 12283 / 163290 (7.5%) | −180.1 | −177.9 | 0.30 |
| FOXA1 SRX1787652 | MCF-7 Breast | 165 / 16329 (1.0%) | 8591 / 163290 (5.3%) | −179.0 | −176.9 | 0.19 |
| CIC SRX13262055 | Astrocytes Neural | 2890 / 16329 (17.7%) | 16220 / 163290 (9.9%) | −179.0 | −176.8 | 1.78 |
| JUN SRX6582172 | Fibroblasts Others | 415 / 16329 (2.5%) | 13042 / 163290 (8.0%) | −179.0 | −176.8 | 0.32 |
| SOX13 SRX2636248 | Hep G2 Liver | 431 / 16329 (2.6%) | 13271 / 163290 (8.1%) | −178.1 | −175.9 | 0.32 |
| ESR1 SRX20282955 | MCF-7 Breast | 322 / 16329 (2.0%) | 11445 / 163290 (7.0%) | −177.9 | −175.7 | 0.28 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 632 / 16329 (3.9%) | 1366 / 163290 (0.8%) | −177.8 | −175.7 | 4.63 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 169 / 16329 (1.0%) | 8635 / 163290 (5.3%) | −177.8 | −175.7 | 0.20 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 597 / 16329 (3.7%) | 15850 / 163290 (9.7%) | −177.6 | −175.5 | 0.38 |
| FOXA1 SRX15430999 | T-47D Breast | 340 / 16329 (2.1%) | 11741 / 163290 (7.2%) | −177.4 | −175.3 | 0.29 |
| FOXA1 SRX1161203 | T-47D Breast | 201 / 16329 (1.2%) | 9239 / 163290 (5.7%) | −177.2 | −175.0 | 0.22 |
| ESR1 SRX2943589 | MCF-7 Breast | 126 / 16329 (0.8%) | 7728 / 163290 (4.7%) | −177.1 | −175.0 | 0.16 |
| AR SRX9109110 | MDA-MB-453 Breast | 618 / 16329 (3.8%) | 16128 / 163290 (9.9%) | −176.6 | −174.5 | 0.38 |
| RELA SRX5938177 | FaDu Others | 278 / 16329 (1.7%) | 10634 / 163290 (6.5%) | −176.4 | −174.3 | 0.26 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 329 / 16329 (2.0%) | 11524 / 163290 (7.1%) | −176.4 | −174.3 | 0.29 |
| EP300 SRX150579 | HeLa Uterus | 185 / 16329 (1.1%) | 8908 / 163290 (5.5%) | −176.4 | −174.3 | 0.21 |
| RNF2 SRX18954719 | SCC-25 Others | 428 / 16329 (2.6%) | 13156 / 163290 (8.1%) | −176.1 | −174.0 | 0.33 |
| JUN SRX2355072 | HAEC Cardiovascular | 416 / 16329 (2.5%) | 12937 / 163290 (7.9%) | −175.4 | −173.3 | 0.32 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1336 / 16329 (8.2%) | 5263 / 163290 (3.2%) | −175.3 | −173.2 | 2.54 |
| CEBPA SRX2630241 | Hep G2 Liver | 384 / 16329 (2.4%) | 12407 / 163290 (7.6%) | −175.2 | −173.1 | 0.31 |
| STAT5B SRX831881 | CD8+ T cells Blood | 266 / 16329 (1.6%) | 131 / 163290 (0.1%) | −175.2 | −173.1 | 20.31 |
| ESR1 SRX371474 | BT-474 Breast | 113 / 16329 (0.7%) | 7398 / 163290 (4.5%) | −175.1 | −173.1 | 0.15 |
| ESR1 SRX10365532 | MCF-7 Breast | 144 / 16329 (0.9%) | 8036 / 163290 (4.9%) | −174.6 | −172.5 | 0.18 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 256 / 16329 (1.6%) | 10183 / 163290 (6.2%) | −174.5 | −172.4 | 0.25 |
| ESR1 SRX8537722 | MCF-7 Breast | 279 / 16329 (1.7%) | 10585 / 163290 (6.5%) | −174.3 | −172.2 | 0.26 |
| FOXA2 SRX100448 | Hep G2 Liver | 342 / 16329 (2.1%) | 11671 / 163290 (7.1%) | −174.1 | −172.0 | 0.29 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 258 / 16329 (1.6%) | 118 / 163290 (0.1%) | −174.0 | −172.0 | 21.86 |
| CDK9 SRX7366783 | MCF-7 Breast | 260 / 16329 (1.6%) | 122 / 163290 (0.1%) | −174.0 | −171.9 | 21.31 |
| JUNB SRX10119383 | MCF 10A Breast | 197 / 16329 (1.2%) | 9068 / 163290 (5.6%) | −174.0 | −171.9 | 0.22 |
| ESR1 SRX20282940 | MCF-7 Breast | 340 / 16329 (2.1%) | 11628 / 163290 (7.1%) | −173.9 | −171.8 | 0.29 |
| FOXA1 SRX1787655 | MCF-7 Breast | 131 / 16329 (0.8%) | 7743 / 163290 (4.7%) | −173.7 | −171.6 | 0.17 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 634 / 16329 (3.9%) | 1409 / 163290 (0.9%) | −173.6 | −171.6 | 4.50 |
| FOXA1 SRX3923517 | MCF-7 Breast | 205 / 16329 (1.3%) | 9211 / 163290 (5.6%) | −173.5 | −171.5 | 0.22 |
| GATAD2A SRX2636506 | Hep G2 Liver | 408 / 16329 (2.5%) | 12741 / 163290 (7.8%) | −173.4 | −171.3 | 0.32 |
| GATA3 SRX6712581 | MCF-7 Breast | 248 / 16329 (1.5%) | 9996 / 163290 (6.1%) | −173.2 | −171.2 | 0.25 |
| FOXA1 SRX1787651 | MCF-7 Breast | 155 / 16329 (0.9%) | 8211 / 163290 (5.0%) | −172.8 | −170.8 | 0.19 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1224 / 16329 (7.5%) | 24464 / 163290 (15.0%) | −172.5 | −170.5 | 0.50 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 211 / 16329 (1.3%) | 9289 / 163290 (5.7%) | −172.4 | −170.4 | 0.23 |
| FOXA1 SRX028634 | MCF-7 Breast | 130 / 16329 (0.8%) | 7683 / 163290 (4.7%) | −172.4 | −170.4 | 0.17 |
| NR3C1 SRX2609664 | HASM2 Lung | 458 / 16329 (2.8%) | 13515 / 163290 (8.3%) | −172.4 | −170.3 | 0.34 |
| FOS SRX3322636 | MCF-7 Breast | 188 / 16329 (1.2%) | 8846 / 163290 (5.4%) | −172.2 | −170.1 | 0.21 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 490 / 16329 (3.0%) | 14008 / 163290 (8.6%) | −172.1 | −170.0 | 0.35 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 257 / 16329 (1.6%) | 10126 / 163290 (6.2%) | −172.1 | −170.0 | 0.25 |
| PGR SRX1012655 | MCF-7 Breast | 176 / 16329 (1.1%) | 8606 / 163290 (5.3%) | −172.0 | −169.9 | 0.20 |
| Epitope tags SRX5877912 | U2OS Bone | 1943 / 16329 (11.9%) | 33591 / 163290 (20.6%) | −171.9 | −169.8 | 0.58 |
| ARID1A SRX5089391 | MCF-7 Breast | 150 / 16329 (0.9%) | 8077 / 163290 (4.9%) | −171.7 | −169.7 | 0.19 |
| DAXX SRX1021630 | PC-3 Prostate | 316 / 16329 (1.9%) | 11146 / 163290 (6.8%) | −171.7 | −169.6 | 0.28 |
| FOXA1 SRX5323829 | T-47D Breast | 151 / 16329 (0.9%) | 8074 / 163290 (4.9%) | −170.8 | −168.7 | 0.19 |
| JUND SRX150408 | HeLa Uterus | 273 / 16329 (1.7%) | 10366 / 163290 (6.3%) | −170.6 | −168.5 | 0.26 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 276 / 16329 (1.7%) | 10409 / 163290 (6.4%) | −170.3 | −168.2 | 0.27 |
| FOXA1 SRX1961157 | T-47D Breast | 343 / 16329 (2.1%) | 11561 / 163290 (7.1%) | −170.2 | −168.1 | 0.30 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 259 / 16329 (1.6%) | 10093 / 163290 (6.2%) | −169.9 | −167.8 | 0.26 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 130 / 16329 (0.8%) | 7610 / 163290 (4.7%) | −169.7 | −167.6 | 0.17 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 472 / 16329 (2.9%) | 13638 / 163290 (8.4%) | −169.6 | −167.6 | 0.35 |
| RELA SRX7055007 | HAEC Cardiovascular | 602 / 16329 (3.7%) | 15627 / 163290 (9.6%) | −169.3 | −167.2 | 0.39 |
| AR SRX9109113 | MDA-MB-453 Breast | 643 / 16329 (3.9%) | 16236 / 163290 (9.9%) | −169.2 | −167.2 | 0.40 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 237 / 16329 (1.5%) | 9670 / 163290 (5.9%) | −169.1 | −167.1 | 0.25 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 635 / 16329 (3.9%) | 16114 / 163290 (9.9%) | −169.1 | −167.0 | 0.39 |
| ESR1 SRX20282953 | MCF-7 Breast | 247 / 16329 (1.5%) | 9849 / 163290 (6.0%) | −168.9 | −166.9 | 0.25 |
| EP300 SRX100540 | SK-N-SH Neural | 487 / 16329 (3.0%) | 13845 / 163290 (8.5%) | −168.8 | −166.8 | 0.35 |
| ESR1 SRX330070 | MCF-7 Breast | 138 / 16329 (0.8%) | 7743 / 163290 (4.7%) | −168.5 | −166.5 | 0.18 |
| ESR1 SRX330067 | MCF-7 Breast | 280 / 16329 (1.7%) | 10421 / 163290 (6.4%) | −168.5 | −166.5 | 0.27 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 312 / 16329 (1.9%) | 10976 / 163290 (6.7%) | −168.5 | −166.4 | 0.28 |
| FOXA1 SRX3923516 | MCF-7 Breast | 217 / 16329 (1.3%) | 9277 / 163290 (5.7%) | −168.3 | −166.3 | 0.23 |
| GATA3 SRX5457550 | MCF-7 Breast | 364 / 16329 (2.2%) | 11846 / 163290 (7.3%) | −168.2 | −166.2 | 0.31 |
| FOXA1 SRX1961158 | T-47D Breast | 314 / 16329 (1.9%) | 10999 / 163290 (6.7%) | −168.1 | −166.1 | 0.29 |
| ESR1 SRX5323873 | MCF-7 Breast | 392 / 16329 (2.4%) | 12302 / 163290 (7.5%) | −168.0 | −166.0 | 0.32 |
| ARID5B SRX10475139 | Hep G2 Liver | 348 / 16329 (2.1%) | 11562 / 163290 (7.1%) | −167.8 | −165.7 | 0.30 |
| EP300 SRX176885 | MCF-7 Breast | 140 / 16329 (0.9%) | 7754 / 163290 (4.7%) | −167.5 | −165.5 | 0.18 |
| ING5 SRX286202 | RKO Digestive tract | 1273 / 16329 (7.8%) | 5007 / 163290 (3.1%) | −167.2 | −165.2 | 2.54 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1665 / 16329 (10.2%) | 7573 / 163290 (4.6%) | −167.0 | −165.0 | 2.20 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 296 / 16329 (1.8%) | 10656 / 163290 (6.5%) | −167.0 | −165.0 | 0.28 |
| ARID5B SRX10475138 | Hep G2 Liver | 555 / 16329 (3.4%) | 14833 / 163290 (9.1%) | −167.0 | −165.0 | 0.37 |
| ESR1 SRX20282971 | MCF-7 Breast | 312 / 16329 (1.9%) | 10931 / 163290 (6.7%) | −167.0 | −165.0 | 0.29 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 231 / 16329 (1.4%) | 9485 / 163290 (5.8%) | −166.7 | −164.7 | 0.24 |
| EP300 SRX1012648 | MCF-7 Breast | 124 / 16329 (0.8%) | 7394 / 163290 (4.5%) | −166.6 | −164.6 | 0.17 |
| FOXA1 SRX100477 | Hep G2 Liver | 370 / 16329 (2.3%) | 11891 / 163290 (7.3%) | −166.6 | −164.5 | 0.31 |
| SP1 SRX190358 | HCT 116 Digestive tract | 519 / 16329 (3.2%) | 14262 / 163290 (8.7%) | −166.5 | −164.5 | 0.36 |
| FOXA1 SRX5323843 | MCF-7 Breast | 145 / 16329 (0.9%) | 7823 / 163290 (4.8%) | −166.3 | −164.3 | 0.19 |
| FOXA1 SRX028635 | MCF-7 Breast | 139 / 16329 (0.9%) | 7681 / 163290 (4.7%) | −165.7 | −163.7 | 0.18 |
| FOS SRX070879 | HUVEC Cardiovascular | 341 / 16329 (2.1%) | 11376 / 163290 (7.0%) | −165.7 | −163.7 | 0.30 |
| FOSL2 SRX190204 | A549 Lung | 313 / 16329 (1.9%) | 10903 / 163290 (6.7%) | −165.7 | −163.7 | 0.29 |
| ESR1 SRX1531796 | MCF-7 Breast | 147 / 16329 (0.9%) | 7845 / 163290 (4.8%) | −165.6 | −163.6 | 0.19 |
| SSRP1 SRX3436567 | HT-1080 Bone | 406 / 16329 (2.5%) | 551 / 163290 (0.3%) | −165.3 | −163.3 | 7.37 |
| ZEB1 SRX13298925 | MCF-7 Breast | 179 / 16329 (1.1%) | 8467 / 163290 (5.2%) | −165.3 | −163.3 | 0.21 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 474 / 16329 (2.9%) | 13521 / 163290 (8.3%) | −165.2 | −163.2 | 0.35 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 488 / 16329 (3.0%) | 13730 / 163290 (8.4%) | −165.0 | −163.0 | 0.36 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 253 / 16329 (1.5%) | 9835 / 163290 (6.0%) | −165.0 | −163.0 | 0.26 |
| ESR1 SRX1469949 | MCF-7 Breast | 163 / 16329 (1.0%) | 8144 / 163290 (5.0%) | −165.0 | −163.0 | 0.20 |
| CEBPB SRX2194250 | SUM 159PT Breast | 403 / 16329 (2.5%) | 12375 / 163290 (7.6%) | −164.9 | −162.9 | 0.33 |
| ESR1 SRX5323871 | MCF-7 Breast | 352 / 16329 (2.2%) | 11518 / 163290 (7.1%) | −164.4 | −162.4 | 0.31 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 227 / 16329 (1.4%) | 9345 / 163290 (5.7%) | −164.4 | −162.4 | 0.24 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1109 / 16329 (6.8%) | 4052 / 163290 (2.5%) | −164.2 | −162.2 | 2.74 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 195 / 16329 (1.2%) | 8740 / 163290 (5.4%) | −164.1 | −162.2 | 0.22 |
| FOXA1 SRX3923518 | MCF-7 Breast | 212 / 16329 (1.3%) | 9058 / 163290 (5.5%) | −164.1 | −162.1 | 0.23 |
| ESR1 SRX4451213 | MCF-7 Breast | 327 / 16329 (2.0%) | 11089 / 163290 (6.8%) | −164.1 | −162.1 | 0.29 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 475 / 16329 (2.9%) | 13486 / 163290 (8.3%) | −163.9 | −161.9 | 0.35 |
| FOXA1 SRX1447317 | MCF-7 Breast | 198 / 16329 (1.2%) | 8791 / 163290 (5.4%) | −163.9 | −161.9 | 0.23 |
| ARID1A SRX5089385 | MCF-7 Breast | 224 / 16329 (1.4%) | 9272 / 163290 (5.7%) | −163.9 | −161.9 | 0.24 |
| ESR1 SRX10365533 | MCF-7 Breast | 132 / 16329 (0.8%) | 7479 / 163290 (4.6%) | −163.7 | −161.7 | 0.18 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 431 / 16329 (2.6%) | 12769 / 163290 (7.8%) | −163.3 | −161.3 | 0.34 |
| TLE3 SRX4815194 | SUM 149PT Breast | 241 / 16329 (1.5%) | 9558 / 163290 (5.9%) | −163.0 | −161.1 | 0.25 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 360 / 16329 (2.2%) | 11604 / 163290 (7.1%) | −162.9 | −161.0 | 0.31 |
| HMG20A SRX2630163 | Hep G2 Liver | 162 / 16329 (1.0%) | 8065 / 163290 (4.9%) | −162.9 | −160.9 | 0.20 |
| FOXA1 SRX11222438 | MCF-7 Breast | 159 / 16329 (1.0%) | 7994 / 163290 (4.9%) | −162.5 | −160.5 | 0.20 |
| FOXA1 SRX5203303 | MCF-7 Breast | 81 / 16329 (0.5%) | 6327 / 163290 (3.9%) | −162.4 | −160.4 | 0.13 |
| CDK9 SRX7366781 | MCF-7 Breast | 242 / 16329 (1.5%) | 113 / 163290 (0.1%) | −162.2 | −160.2 | 21.42 |
| JUN SRX2355073 | HAEC Cardiovascular | 421 / 16329 (2.6%) | 12570 / 163290 (7.7%) | −162.1 | −160.1 | 0.33 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 531 / 16329 (3.3%) | 14289 / 163290 (8.8%) | −162.1 | −160.1 | 0.37 |
| FOXA1 SRX6878603 | LNCAP Prostate | 370 / 16329 (2.3%) | 11735 / 163290 (7.2%) | −161.9 | −159.9 | 0.32 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 344 / 16329 (2.1%) | 11302 / 163290 (6.9%) | −161.9 | −159.9 | 0.30 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 458 / 16329 (2.8%) | 13150 / 163290 (8.1%) | −161.8 | −159.9 | 0.35 |
| ESR1 SRX1012632 | MCF-7 Breast | 137 / 16329 (0.8%) | 7528 / 163290 (4.6%) | −161.7 | −159.7 | 0.18 |
| FOS SRX150664 | HUVEC Cardiovascular | 442 / 16329 (2.7%) | 12889 / 163290 (7.9%) | −161.6 | −159.6 | 0.34 |
| ESR1 SRX3110725 | MCF-7 Breast | 287 / 16329 (1.8%) | 10323 / 163290 (6.3%) | −161.6 | −159.6 | 0.28 |
| TEAD3 SRX2636153 | Hep G2 Liver | 838 / 16329 (5.1%) | 18757 / 163290 (11.5%) | −161.6 | −159.6 | 0.45 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 291 / 16329 (1.8%) | 10386 / 163290 (6.4%) | −161.3 | −159.3 | 0.28 |
| PROX1 SRX3230397 | Hep G2 Liver | 223 / 16329 (1.4%) | 9172 / 163290 (5.6%) | −161.2 | −159.3 | 0.24 |
| ESR1 SRX3123829 | MCF-7 Breast | 170 / 16329 (1.0%) | 8169 / 163290 (5.0%) | −161.1 | −159.2 | 0.21 |
| RNF2 SRX18954704 | FaDu Others | 833 / 16329 (5.1%) | 18667 / 163290 (11.4%) | −161.0 | −159.1 | 0.45 |
| FOXA1 SRX3931033 | MCF-7 Breast | 196 / 16329 (1.2%) | 8667 / 163290 (5.3%) | −161.0 | −159.0 | 0.23 |
| NR3C1 SRX10976921 | A549 Lung | 218 / 16329 (1.3%) | 9068 / 163290 (5.6%) | −160.8 | −158.9 | 0.24 |
| ARID1A SRX5089382 | MCF-7 Breast | 216 / 16329 (1.3%) | 9027 / 163290 (5.5%) | −160.7 | −158.7 | 0.24 |
| ESR1 SRX330069 | MCF-7 Breast | 186 / 16329 (1.1%) | 8460 / 163290 (5.2%) | −160.5 | −158.6 | 0.22 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 411 / 16329 (2.5%) | 12351 / 163290 (7.6%) | −160.4 | −158.4 | 0.33 |
| ESR1 SRX20282959 | MCF-7 Breast | 112 / 16329 (0.7%) | 6964 / 163290 (4.3%) | −160.3 | −158.3 | 0.16 |
| ESR1 SRX8537723 | MCF-7 Breast | 254 / 16329 (1.6%) | 9702 / 163290 (5.9%) | −160.2 | −158.3 | 0.26 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 313 / 16329 (1.9%) | 10725 / 163290 (6.6%) | −160.2 | −158.2 | 0.29 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 219 / 16329 (1.3%) | 9064 / 163290 (5.6%) | −160.0 | −158.0 | 0.24 |
| GATAD2A SRX2636507 | Hep G2 Liver | 359 / 16329 (2.2%) | 11484 / 163290 (7.0%) | −159.8 | −157.9 | 0.31 |
| TRP47 SRX4548329 | THP-1 Blood | 2449 / 16329 (15.0%) | 13418 / 163290 (8.2%) | −159.6 | −157.7 | 1.83 |
| NR3C1 SRX19024866 | MCF-7 Breast | 88 / 16329 (0.5%) | 6409 / 163290 (3.9%) | −159.4 | −157.5 | 0.14 |
| NR3C1 SRX2609665 | HASM2 Lung | 374 / 16329 (2.3%) | 11713 / 163290 (7.2%) | −159.3 | −157.4 | 0.32 |
| ESR1 SRX1012629 | MCF-7 Breast | 190 / 16329 (1.2%) | 8500 / 163290 (5.2%) | −159.2 | −157.3 | 0.22 |
| FOS SRX3322637 | MCF-7 Breast | 162 / 16329 (1.0%) | 7952 / 163290 (4.9%) | −159.0 | −157.1 | 0.20 |
| JUNB SRX10119384 | MCF 10A Breast | 191 / 16329 (1.2%) | 8505 / 163290 (5.2%) | −158.8 | −156.9 | 0.22 |
| FOXA1 SRX3923515 | MCF-7 Breast | 170 / 16329 (1.0%) | 8101 / 163290 (5.0%) | −158.8 | −156.9 | 0.21 |
| EP300 SRX10976215 | A549 Lung | 300 / 16329 (1.8%) | 10458 / 163290 (6.4%) | −158.8 | −156.8 | 0.29 |
| FOXA1 SRX1161205 | T-47D Breast | 156 / 16329 (1.0%) | 7824 / 163290 (4.8%) | −158.7 | −156.8 | 0.20 |
| ESR1 SRX20282938 | MCF-7 Breast | 258 / 16329 (1.6%) | 9727 / 163290 (6.0%) | −158.7 | −156.7 | 0.27 |
| CEBPA SRX4705113 | MOLM-13 Blood | 809 / 16329 (5.0%) | 18219 / 163290 (11.2%) | −158.3 | −156.4 | 0.44 |
| VGLL1 SRX18013277 | FULVR Breast | 124 / 16329 (0.8%) | 7162 / 163290 (4.4%) | −158.3 | −156.3 | 0.17 |
| MITF SRX7368255 | Hermes 3C Epidermis | 995 / 16329 (6.1%) | 20779 / 163290 (12.7%) | −158.0 | −156.0 | 0.48 |
| RNF2 SRX18954702 | FaDu Others | 796 / 16329 (4.9%) | 18018 / 163290 (11.0%) | −157.8 | −155.9 | 0.44 |
| FOXA1 SRX1161207 | T-47D Breast | 113 / 16329 (0.7%) | 6908 / 163290 (4.2%) | −157.5 | −155.6 | 0.16 |
| GATA3 SRX100559 | T-47D Breast | 376 / 16329 (2.3%) | 11685 / 163290 (7.2%) | −157.5 | −155.5 | 0.32 |
| MEAF6 DRX300417 | 293 Kidney | 1464 / 16329 (9.0%) | 6421 / 163290 (3.9%) | −157.3 | −155.4 | 2.28 |
| FOXA1 SRX3923519 | MCF-7 Breast | 195 / 16329 (1.2%) | 8536 / 163290 (5.2%) | −157.3 | −155.4 | 0.23 |
| LEO1 SRX1873456 | SEM Blood | 1385 / 16329 (8.5%) | 5901 / 163290 (3.6%) | −157.2 | −155.3 | 2.35 |
| ESR1 SRX5323872 | MCF-7 Breast | 329 / 16329 (2.0%) | 10890 / 163290 (6.7%) | −156.8 | −154.9 | 0.30 |
| MAU2 SRX15710550 | Fibroblasts Others | 580 / 16329 (3.6%) | 14843 / 163290 (9.1%) | −156.8 | −154.9 | 0.39 |
| ESR1 SRX10365558 | MCF-7 Breast | 214 / 16329 (1.3%) | 8871 / 163290 (5.4%) | −156.7 | −154.8 | 0.24 |
| FOXA1 SRX190181 | A549 Lung | 233 / 16329 (1.4%) | 9212 / 163290 (5.6%) | −156.5 | −154.6 | 0.25 |
| FOXA1 SRX9604647 | LNCAP Prostate | 532 / 16329 (3.3%) | 14105 / 163290 (8.6%) | −156.5 | −154.6 | 0.38 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 212 / 16329 (1.3%) | 8825 / 163290 (5.4%) | −156.4 | −154.5 | 0.24 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 642 / 16329 (3.9%) | 15743 / 163290 (9.6%) | −156.4 | −154.5 | 0.41 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 272 / 16329 (1.7%) | 9894 / 163290 (6.1%) | −156.2 | −154.3 | 0.27 |
| FOXA1 SRX3931056 | MCF-7 Breast | 184 / 16329 (1.1%) | 8296 / 163290 (5.1%) | −156.2 | −154.3 | 0.22 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 457 / 16329 (2.8%) | 12933 / 163290 (7.9%) | −156.1 | −154.2 | 0.35 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 98 / 16329 (0.6%) | 6537 / 163290 (4.0%) | −155.9 | −154.0 | 0.15 |
| FOXA1 SRX190282 | A549 Lung | 222 / 16329 (1.4%) | 8994 / 163290 (5.5%) | −155.9 | −154.0 | 0.25 |
| ARID1A SRX5089388 | MCF-7 Breast | 153 / 16329 (0.9%) | 7681 / 163290 (4.7%) | −155.8 | −153.9 | 0.20 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 215 / 16329 (1.3%) | 8862 / 163290 (5.4%) | −155.8 | −153.8 | 0.24 |
| FOXA2 SRX10475773 | Hep G2 Liver | 416 / 16329 (2.5%) | 12267 / 163290 (7.5%) | −155.5 | −153.6 | 0.34 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 462 / 16329 (2.8%) | 12984 / 163290 (8.0%) | −155.3 | −153.4 | 0.36 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 620 / 16329 (3.8%) | 15374 / 163290 (9.4%) | −155.2 | −153.3 | 0.40 |
| CEBPB SRX190345 | MCF-7 Breast | 258 / 16329 (1.6%) | 9604 / 163290 (5.9%) | −154.9 | −153.0 | 0.27 |
| ESR1 SRX5323878 | MCF-7 Breast | 334 / 16329 (2.0%) | 10904 / 163290 (6.7%) | −154.7 | −152.8 | 0.31 |
| FOXA1 SRX5323830 | T-47D Breast | 182 / 16329 (1.1%) | 8215 / 163290 (5.0%) | −154.7 | −152.8 | 0.22 |
| NR3C1 SRX8520802 | HCC1187 Breast | 247 / 16329 (1.5%) | 9403 / 163290 (5.8%) | −154.7 | −152.8 | 0.26 |
| NR3C1 SRX10977372 | A549 Lung | 178 / 16329 (1.1%) | 8129 / 163290 (5.0%) | −154.5 | −152.6 | 0.22 |
| EP300 SRX1012643 | MCF-7 Breast | 97 / 16329 (0.6%) | 6472 / 163290 (4.0%) | −154.3 | −152.4 | 0.15 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 178 / 16329 (1.1%) | 8122 / 163290 (5.0%) | −154.2 | −152.3 | 0.22 |
| FOXA1 SRX13814018 | 5637 Others | 206 / 16329 (1.3%) | 8635 / 163290 (5.3%) | −153.9 | −152.0 | 0.24 |
| SP1 SRX190269 | A549 Lung | 509 / 16329 (3.1%) | 13655 / 163290 (8.4%) | −153.8 | −151.9 | 0.37 |
| EP300 SRX1012644 | MCF-7 Breast | 131 / 16329 (0.8%) | 7175 / 163290 (4.4%) | −153.7 | −151.8 | 0.18 |
| MEAF6 DRX234811 | 293 Kidney | 1580 / 16329 (9.7%) | 7282 / 163290 (4.5%) | −153.5 | −151.6 | 2.17 |
| NR3C1 SRX2609662 | HASM2 Lung | 415 / 16329 (2.5%) | 12179 / 163290 (7.5%) | −153.5 | −151.6 | 0.34 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1242 / 16329 (7.6%) | 23869 / 163290 (14.6%) | −153.2 | −151.3 | 0.52 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 412 / 16329 (2.5%) | 12115 / 163290 (7.4%) | −153.1 | −151.2 | 0.34 |
| RELA SRX7054617 | HAEC Cardiovascular | 418 / 16329 (2.6%) | 12206 / 163290 (7.5%) | −152.9 | −151.0 | 0.34 |
| WWTR1 SRX10119368 | MCF 10A Breast | 234 / 16329 (1.4%) | 9118 / 163290 (5.6%) | −152.9 | −151.0 | 0.26 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1242 / 16329 (7.6%) | 23846 / 163290 (14.6%) | −152.7 | −150.9 | 0.52 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 402 / 16329 (2.5%) | 11942 / 163290 (7.3%) | −152.6 | −150.7 | 0.34 |
| FOXA1 SRX3931032 | MCF-7 Breast | 186 / 16329 (1.1%) | 8215 / 163290 (5.0%) | −152.3 | −150.4 | 0.23 |
| SOX5 SRX2636544 | Hep G2 Liver | 340 / 16329 (2.1%) | 10918 / 163290 (6.7%) | −152.2 | −150.3 | 0.31 |
| Epitope tags SRX10549778 | K-562 Blood | 1062 / 16329 (6.5%) | 3956 / 163290 (2.4%) | −152.0 | −150.1 | 2.68 |
| ESR1 SRX5323877 | MCF-7 Breast | 257 / 16329 (1.6%) | 9490 / 163290 (5.8%) | −151.8 | −150.0 | 0.27 |
| NR3C1 SRX17639413 | A549 Lung | 223 / 16329 (1.4%) | 8884 / 163290 (5.4%) | −151.8 | −149.9 | 0.25 |
| ESR1 SRX1012633 | MCF-7 Breast | 156 / 16329 (1.0%) | 7616 / 163290 (4.7%) | −151.6 | −149.7 | 0.20 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 649 / 16329 (4.0%) | 1680 / 163290 (1.0%) | −151.4 | −149.5 | 3.86 |
| Epitope tags SRX5877914 | U2OS Bone | 2004 / 16329 (12.3%) | 33327 / 163290 (20.4%) | −151.1 | −149.2 | 0.60 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 354 / 16329 (2.2%) | 11108 / 163290 (6.8%) | −151.0 | −149.1 | 0.32 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 691 / 16329 (4.2%) | 16247 / 163290 (9.9%) | −150.9 | −149.0 | 0.43 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 331 / 16329 (2.0%) | 10722 / 163290 (6.6%) | −150.9 | −149.0 | 0.31 |
| JUN SRX6582163 | BJ-5ta Epidermis | 445 / 16329 (2.7%) | 12561 / 163290 (7.7%) | −150.9 | −149.0 | 0.35 |
| ESR1 SRX330068 | MCF-7 Breast | 142 / 16329 (0.9%) | 7315 / 163290 (4.5%) | −150.7 | −148.8 | 0.19 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 247 / 16329 (1.5%) | 9275 / 163290 (5.7%) | −150.6 | −148.7 | 0.27 |
| ESR1 SRX2912055 | MCF-7 Breast | 110 / 16329 (0.7%) | 6648 / 163290 (4.1%) | −150.5 | −148.6 | 0.17 |
| ESR1 SRX10365534 | MCF-7 Breast | 79 / 16329 (0.5%) | 5959 / 163290 (3.6%) | −150.5 | −148.6 | 0.13 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 580 / 16329 (3.6%) | 14595 / 163290 (8.9%) | −150.2 | −148.4 | 0.40 |
| NR3C1 SRX10977357 | A549 Lung | 201 / 16329 (1.2%) | 8430 / 163290 (5.2%) | −150.2 | −148.3 | 0.24 |
| MYC SRX150570 | MCF 10A Breast | 223 / 16329 (1.4%) | 8833 / 163290 (5.4%) | −150.2 | −148.3 | 0.25 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 415 / 16329 (2.5%) | 12062 / 163290 (7.4%) | −150.1 | −148.2 | 0.34 |
| FOXA1 SRX6860635 | T-47D Breast | 255 / 16329 (1.6%) | 9398 / 163290 (5.8%) | −150.0 | −148.2 | 0.27 |
| ESR1 SRX1469951 | MCF-7 Breast | 164 / 16329 (1.0%) | 7720 / 163290 (4.7%) | −149.9 | −148.0 | 0.21 |
| GFP SRX6949256 | HeLa Uterus | 388 / 16329 (2.4%) | 11615 / 163290 (7.1%) | −149.7 | −147.8 | 0.33 |
| SS18 SRX10881848 | G-401 Kidney | 483 / 16329 (3.0%) | 13111 / 163290 (8.0%) | −149.7 | −147.8 | 0.37 |
| RNF2 SRX18954706 | SCC-25 Others | 434 / 16329 (2.7%) | 12340 / 163290 (7.6%) | −149.5 | −147.6 | 0.35 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 407 / 16329 (2.5%) | 11909 / 163290 (7.3%) | −149.4 | −147.6 | 0.34 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 389 / 16329 (2.4%) | 11615 / 163290 (7.1%) | −149.1 | −147.3 | 0.33 |
| NR3C1 SRX10977373 | A549 Lung | 175 / 16329 (1.1%) | 7914 / 163290 (4.8%) | −149.1 | −147.2 | 0.22 |
| FOXL2 SRX6957477 | KGN Gonad | 364 / 16329 (2.2%) | 11204 / 163290 (6.9%) | −149.0 | −147.2 | 0.32 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 127 / 16329 (0.8%) | 6959 / 163290 (4.3%) | −149.0 | −147.1 | 0.18 |
| FOXA3 SRX2630190 | Hep G2 Liver | 285 / 16329 (1.7%) | 9884 / 163290 (6.1%) | −148.9 | −147.1 | 0.29 |
| NFYB SRX16608147 | HeLa Uterus | 259 / 16329 (1.6%) | 184 / 163290 (0.1%) | −148.8 | −147.0 | 14.08 |
| BMI1 SRX644729 | 293 Kidney | 234 / 16329 (1.4%) | 128 / 163290 (0.1%) | −148.8 | −146.9 | 18.28 |
| PRMT1 SRX3642947 | Keratinocytes Epidermis | 195 / 16329 (1.2%) | 8275 / 163290 (5.1%) | −148.7 | −146.8 | 0.24 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 220 / 16329 (1.3%) | 8729 / 163290 (5.3%) | −148.6 | −146.7 | 0.25 |
| NR3C1 SRX19024870 | MCF-7 Breast | 92 / 16329 (0.6%) | 6201 / 163290 (3.8%) | −148.6 | −146.7 | 0.15 |
| FOXA1 SRX9604645 | LNCAP Prostate | 510 / 16329 (3.1%) | 13473 / 163290 (8.3%) | −148.4 | −146.5 | 0.38 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 510 / 16329 (3.1%) | 13469 / 163290 (8.2%) | −148.2 | −146.4 | 0.38 |
| TLE3 SRX4815193 | SUM 149PT Breast | 353 / 16329 (2.2%) | 11000 / 163290 (6.7%) | −148.2 | −146.3 | 0.32 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 135 / 16329 (0.8%) | 7097 / 163290 (4.3%) | −148.1 | −146.3 | 0.19 |
| RELA SRX7054657 | HAEC Cardiovascular | 399 / 16329 (2.4%) | 11723 / 163290 (7.2%) | −147.7 | −145.9 | 0.34 |
| FOXA1 SRX1161172 | MCF-7 Breast | 358 / 16329 (2.2%) | 11064 / 163290 (6.8%) | −147.7 | −145.9 | 0.32 |
| NFIL3 SRX2630334 | Hep G2 Liver | 277 / 16329 (1.7%) | 9695 / 163290 (5.9%) | −147.4 | −145.5 | 0.29 |
| JUND SRX699738 | HCASMC Cardiovascular | 502 / 16329 (3.1%) | 13318 / 163290 (8.2%) | −147.3 | −145.5 | 0.38 |
| FOXA1 SRX219284 | LNCAP Prostate | 487 / 16329 (3.0%) | 13075 / 163290 (8.0%) | −147.1 | −145.2 | 0.37 |
| RXRB SRX2636027 | Hep G2 Liver | 384 / 16329 (2.4%) | 11460 / 163290 (7.0%) | −147.0 | −145.2 | 0.34 |
| EP300 SRX717860 | HeLa Uterus | 217 / 16329 (1.3%) | 8628 / 163290 (5.3%) | −147.0 | −145.1 | 0.25 |
| JUN SRX6582165 | BJ-5ta Epidermis | 703 / 16329 (4.3%) | 16260 / 163290 (10.0%) | −146.8 | −144.9 | 0.43 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 432 / 16329 (2.6%) | 12210 / 163290 (7.5%) | −146.7 | −144.8 | 0.35 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 357 / 16329 (2.2%) | 11009 / 163290 (6.7%) | −146.6 | −144.8 | 0.32 |
| NR3C1 SRX2609666 | HASM2 Lung | 342 / 16329 (2.1%) | 10762 / 163290 (6.6%) | −146.6 | −144.8 | 0.32 |
| EP300 SRX10976625 | A549 Lung | 192 / 16329 (1.2%) | 8152 / 163290 (5.0%) | −146.5 | −144.7 | 0.24 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 93 / 16329 (0.6%) | 6166 / 163290 (3.8%) | −146.4 | −144.6 | 0.15 |
| Epitope tags SRX20741925 | Hep G2 Liver | 628 / 16329 (3.8%) | 15163 / 163290 (9.3%) | −146.4 | −144.6 | 0.41 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 498 / 16329 (3.0%) | 13222 / 163290 (8.1%) | −146.4 | −144.6 | 0.38 |
| ESR1 SRX2881001 | MCF-7 Breast | 179 / 16329 (1.1%) | 7905 / 163290 (4.8%) | −146.3 | −144.5 | 0.23 |
| FOXA1 SRX5203294 | MCF-7 Breast | 80 / 16329 (0.5%) | 5873 / 163290 (3.6%) | −146.3 | −144.5 | 0.14 |
| ZEB1 SRX13298924 | MCF-7 Breast | 150 / 16329 (0.9%) | 7342 / 163290 (4.5%) | −146.2 | −144.4 | 0.20 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 639 / 16329 (3.9%) | 15315 / 163290 (9.4%) | −146.2 | −144.4 | 0.42 |
| KMT2C SRX1787675 | MCF-7 Breast | 307 / 16329 (1.9%) | 10161 / 163290 (6.2%) | −146.0 | −144.1 | 0.30 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 587 / 16329 (3.6%) | 14537 / 163290 (8.9%) | −145.9 | −144.1 | 0.40 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 827 / 16329 (5.1%) | 2679 / 163290 (1.6%) | −145.8 | −144.0 | 3.09 |
| FOXA1 SRX5323846 | MCF-7 Breast | 115 / 16329 (0.7%) | 6620 / 163290 (4.1%) | −145.8 | −143.9 | 0.17 |
| PGR SRX3990986 | T-47D Breast | 302 / 16329 (1.8%) | 10066 / 163290 (6.2%) | −145.7 | −143.9 | 0.30 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 230 / 16329 (1.4%) | 8817 / 163290 (5.4%) | −145.6 | −143.8 | 0.26 |
| FOXA1 SRX2642368 | VCaP Prostate | 446 / 16329 (2.7%) | 12389 / 163290 (7.6%) | −145.5 | −143.7 | 0.36 |
| SMAD3 SRX366168 | NCI-H441 Lung | 316 / 16329 (1.9%) | 10288 / 163290 (6.3%) | −145.3 | −143.5 | 0.31 |
Showing first 500 of 19124 rows.